Navigation Links
Tobacco plant based Vaccine against Plague

Researchers from the Biodesign Institute, Arizona State University have successfully produced Plague vaccines from Tobacco plants. The researchers were able to produce vaccines from bioengineered // plant which is found to be effective against guinea pigs which were exposed to pneumonic plague bacterium. The researchers are to start a clinical trial of the new vaccine in human to study the efficacy of the new vaccine. The researchers have reported the results of this study n the Journal Proceedings of the National Academy of Sciences.

Plague is an infectious disease caused by the bacterium Yersinia pestis, transmission mostly occurs by transmission of bacterium from rodent flea bite or handling of infected animal. Pneumonic plague can occur by inhaling infected droplet containing the flea. WHO has reported an early outbreak of 1000-3000 plague cases every year. Plague causes painful swollen lymph node with fever and exhaustion. The infection is highly progressive and can lead to fatality if antibiotic treatment is started immediately after diagnosis.

Though natural plague bacterium have been effectively controlled there as been an increased threat of genetically modified resistant strains of Yersinia pestis produced as a bioweapon to cause bio terrorism. Scientists are not sure whether these antibiotics would work effectively against this mutated bacterium which has led to an increase need to produce vaccine against plague infection.

Researchers have produced Recombinant subunit vaccines against plague by using two plague antigens F1, V and a combination of these two antigens as it gives the option of producing the required antigen vaccines depending on the strain of the bacterium which causes the outbreak. By injecting the antigens in the plant the researchers were able to produce high quantity of stable antigens within 10 days of infecting the plant, when injecting on guinea pigs either intramuscular or subcutaneous the guinea
'"/>




Page: 1 2

Related medicine news :

1. Tobacco chewing leads to dental caries
2. Tobacco and alcohol connected to larger health problems
3. Vegetables decrease Tobacco Toxins
4. Exposure To Tobacco Smoke Can Lead To Sickle Cell Crisis
5. Tobacco Found To Trigger Familial Pancreatic Cancer
6. Tobacco smoke increases the levels of Cox 2.
7. Aggressive Tobacco taxation policy can reduce cigarette smoking
8. Role Of Tobacco In Development Of Oral Cancer And Heart Disease
9. Women More Prone To Risk of Colorectal Cancer from Tobacco
10. WHO Intensifies Anti-Tobacco war
11. New Zealand Researchers Call For Tobacco-Free Society
Post Your Comments:
(Date:10/6/2008)... Millions of women suffer with symptoms of men...conomic rescue plan. But the effects of our curren...aking it increasingly difficult for U.S. women to ...kstead announces new cost effective drug-free guid...a prescription. , Las Veg...
(Date:10/6/2008)..., Oct. 6 /PRNewswire-FirstCall/ -- SAP AG (NYSE: ...ed SAP as senior vice president,of the Healthcare ...e,August 1, 2008, Mr. Papandrea will help drive SA...egic software solutions to healthcare,organization...onjunction,with the 3rd annual Ambassadors Dinner ...
(Date:10/5/2008)...e blood test may help detect serious bacterial inf...lood stream infections in young infants who come t...ave no clear cause. Researchers at Children,s Hosp...eorge Washington University, show that a new diagn...y infants at high risk for SBIs while potentially ...
(Date:10/5/2008)...ittle exercise goes a long way toward helping seve...fe and complete important daily tasks, according t... , In a pre-program assessment where patients re...e per week, individuals who were more active repor...rted improvements in their ability to perform dail...
Breaking Medicine News(10 mins):Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 2Health News:Menopause Relief: Award-Winning Physician Announces New Cost Effective Drug-Free Guidelines 3Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 2Health News:SAP Appoints John Papandrea to Lead Healthcare Business Unit 3Health News:New test could help catch serious infections in babies 2Health News:A little exercise goes a long way for severely obese 2
...ed as a process of bewitchment, but scientists hav...meets the eye. They say female chemical messengers...ng plain women are more attractive and beautiful w...ually are.// Pheromones - the colourless, odourle...
...e pill may find themselves less responsive to the ...hers. The study, published in the journal Human Re...t distinctive smells such as musk - while taking a...at women who were not taking the Pill experienced ...
...ing collagen into the vocal cords improves voice p...nt symptoms of Parkinson's disease is the deterior...s. This problem is known as hypophonia, and is cau...malities in the area of the voice box or larynx.//...
...se might explain common digestive symptoms like ga... of Iowa have been investigating the link between ... bowel syndrome (IBS), a common disorder character...es in bowel habit. Fructose is the sugar found in ...
Other Medicine News:Health News:The phenomenon of sexual attraction, 2
(Date:10/6/2008)...EW, Calif. and SEATTLE, Oct. 6 /- Com...ation human genome sequencing,company, and the Ins...heir,partnership to conduct populationwide human g...lete Genomics will use its proprietary,DNA sequenc...es provided by,ISB. Then, once proof-of-concept ha...
(Date:10/6/2008)...Procedure May Eliminate 6 Weeks of Radiation Thera... over the Internet Wednesday, October 22, 2008,...plorehealth , HAMPTON, Va., Oct. 6 /... was diagnosed with breast cancer in May. Would sh... about radiation or chemotherapy?, , To view the...
(Date:10/5/2008)...lished in New England Journal of Medicine reaffirm...ofile of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Co...of the,UPLIFT (Understanding Potential Long-term I...that SPIRIVA(R) HandiHaler(R) (tiotropium bromide,... function for up to 4,years as measured by FEV(1) ...
(Date:10/3/2008)... to Study B-Raf Kinase Inhibitors for Cancer Treat.... 3 /-,Eli Lilly and Compan...aceuticals, LLC today announced that the two compa...de licensing agreement related to,Deciphera,s prec...dy of,potential oncology therapeutics., The colla...
Breaking Medicine Technology:Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2Photos: Sentara Joins 4 U.S. Hospitals in International 'TARGIT' Breast Cancer Trial 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 2Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement 3Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 1Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 2Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals LLC 4510 3Commerzbank Goes Live With Misys Risk Vision 5 4 Following a Successful On Schedule Implementation Project 16446 1Commerzbank Goes Live With Misys Risk Vision 5 4 Following a Successful On Schedule Implementation Project 16446 2Researchers pilot new electronic system for infectious illness 16444 1Researchers pilot new electronic system for infectious illness 16444 2Carbon nanotubes made into conductive flexible stained glass 4504 1Carbon nanotubes made into conductive flexible stained glass 4504 2
...1, 2007 - Opexa,Therapeutics, Inc. (NASDAQ:OPXA), ...alization of cell therapies, made a poster,present... of,Clinical Immunology Societies (FOCIS) in San D...p; Marina. The poster, entitled,"Identifying New I...ng Multiple Sclerosis Patients" was presented on S...
...t Federation of,Clinical Immunology Societies (FOC...007 /PRNewswire-FirstCall/ --,Orchestra Therapeuti...sitive new data from its completed Phase II open-l...ell Receptor (TCR) peptide,vaccine for the treatme... The new data, presented last week at the Federati...
Other Medicine Technology:Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 2Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 3Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 4Orchestra Therapeutics Announces New Phase II Clinical Data on,NeuroVax Demonstrating Marked Expansion of Regulatory T Cell,Populations in Patients With Multiple Sclerosis 5
With this unique offer, you can prepare for any molecular biology application. Pipetman P2 and P10 are ideal for enzymes and reagents, and P100 is perfect for buffers. Kits include Diamond Filter Tip
The RapidPCP test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of Phencyclidine in human urine specimens above,a cut-off level of 25 ng/mL. Th
... an immunochromatography based one step,in vitro t...of Opiates and its metabolite in,human urine speci...e a cut-off level,of 2,000ng/mL can be detected. T...are,location and is for use by Healthcare Professi...
All of DOA Panel Test is an immunochromatography based one step in vitro test. It is designed,for qualitative determination of drug substances in human urine specimens. This assay has not,been evalua
Medicine Products: